NBY - NovaBay Pharmaceuticals, Inc.
0.5598
0.030 5.341%
Share volume: 20,273
Last Updated: 04-14-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.04%
PREVIOUS CLOSE
CHG
CHG%
$0.53
0.03
0.06%
Summary score
18%
Profitability
8%
Dept financing
31%
Liquidity
75%
Performance
10%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-455.95%
Return on assets
-17.72%
Return on sales
-35.17%
Return on invested capital
152.6%
Total debt ratio
82.55%
Debt ratio change over timeo
0.37%
Current Ratio
1.96%
Quick Ratio
1.77%
Cash Position Ratio
1.22%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-27.37%
Return on sales
-43.47%
Return on invested capital
0%
Total debt ratio
72.5%
Debt ratio change over timeo
-0.52%
Current Ratio
1.15%
Quick Ratio
0.91%
Cash Position Ratio
0.39%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-27.37%
Return on sales
-43.47%
Return on invested capital
0%
Total debt ratio
72.5%
Debt ratio change over time
-0.52%
Current Ratio
1.15%
Quick Ratio
0.91%
Cash Position Ratio
0.39%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-1218.84%
Return on assets
-118.87%
Return on sales
-147.22%
Return on invested capital
274.47%
Total debt ratio
37.36%
Debt ratio change over time
0.37%
Current Ratio
2.77%
Quick Ratio
2.52%
Cash Position Ratio
1.63%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NBY | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | -455.95% | 18.83% | 17.34% | 0% |
| Return on assets | -17.72% | 4.14% | 8.21% | 0% |
| Return on sales | -35.17% | 27.93% | 41.18% | 0% |
| Return on invested capital | 152.6% | 9.79% | -219.55% | 0% |
| Profitability | 25% | 56% | 73% | 0% |
| Total debt ratio | 82.55% | 82.52% | 55.88% | 0% |
| Debt ratio change over time | 0.37% | -13.08% | -0.73% | 0% |
| Dept financing | 50% | 25% | 17% | 0% |
| Current Ratio | 1.15% | 1.13% | 0% | 0% |
| Quick Ratio | 0.91% | 0.87% | 0% | 0% |
| Cash Position Ratio | 0.39% | 0.12% | 0% | 0% |
| Liquididy | 75% | 32% | 33% | 0% |
| Short-term ratios | NBY | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 13.31% | 0% | 0% |
| Return on assets | -27.37% | 4.46% | 0% | 0% |
| Return on sales | -43.47% | 29.96% | 0% | 0% |
| Return on invested capital | 0% | 10.68% | 0% | 0% |
| Profitability | 0% | 100% | 0% | 0% |
| Total debt ratio | 72.5% | 81.12% | 0% | 0% |
| Debt ratio change over time | -0.52% | -58.72% | 0% | 0% |
| Dept financing | 22% | 25% | 25% | 0% |
| Current Ratio | 1.15% | 1.13% | 0% | 0% |
| Quick Ratio | 0.91% | 0.87% | 0% | 0% |
| Cash Position Ratio | 0.39% | 0.12% | 0% | 0% |
| Liquididy | 75% | 56% | 0% | 0% |
